Core Laboratories Inc. /DE/ Quarterly Liabilities and Equity in USD from Q4 2022 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Core Laboratories Inc. /DE/ quarterly Liabilities and Equity history and growth rate from Q4 2022 to Q3 2024.
Core Laboratories Inc. /DE/ Liabilities and Equity for the quarter ending September 30, 2024 was $600M, a 1.36% increase year-over-year.

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$600M	+$8.05M	+1.36%	Sep 30, 2024	10-Q	2024-10-24
Q2 2024	$598M	-$4.05M	-0.67%	Jun 30, 2024	10-Q	2024-07-25
Q1 2024	$588M			Mar 31, 2024	10-Q	2024-04-25
Q4 2023	$586M	+$8.04M	+1.39%	Dec 31, 2023	10-Q	2024-10-24
Q3 2023	$592M			Sep 30, 2023	10-Q	2023-11-02
Q2 2023	$602M			Jun 30, 2023	10-Q	2023-07-27
Q4 2022	$578M			Dec 31, 2022	10-K	2024-02-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.